Overexpression of TTRAP inhibits cell growth and induces apoptosis in osteosarcoma cells

Caihong Zhou1, Qi Shen, Jinglun Xue

  • 1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China.

BMB Reports
|February 26, 2013
PubMed

Insights

Overexpressing the TTRAP protein significantly inhibited osteosarcoma cell growth and triggered apoptosis. Mutations affecting TTRAP

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • TTRAP is a multi-functional protein implicated in crucial cellular processes.
  • Its specific roles in osteosarcoma tumorigenesis require further elucidation.

Purpose of the Study:

  • To investigate the effect of TTRAP overexpression on osteosarcoma cell behavior.
  • To explore the functional significance of TTRAP's tyrosyl-DNA phosphodiesterase activity in cancer.

Main Methods:

  • Lentivirus-mediated gene delivery for TTRAP overexpression in U2OS and Saos-2 cells.
  • Assessment of cell proliferation, colony formation, apoptosis, and cell cycle progression.
  • Analysis of caspase-3/-7 activity and cyclin B1 expression.
  • Utilized site-directed mutagenesis to evaluate TTRAP's enzymatic activity.

Main Results:

  • Ectopic TTRAP expression significantly suppressed osteosarcoma cell growth and colony formation.
  • TTRAP overexpression induced apoptosis in U2OS cells and G2/M cell cycle arrest in Saos-2 cells.
  • Mutations in TTRAP's tyrosyl-DNA phosphodiesterase domain, specifically TTRAP(E152A), diminished its growth-inhibitory effects.

Conclusions:

  • TTRAP acts as a suppressor of osteosarcoma cell proliferation and survival.
  • The tyrosyl-DNA phosphodiesterase activity of TTRAP is critical for its anti-proliferative function.
  • These findings contribute to understanding TTRAP's role in cancer regulation and offer potential therapeutic insights.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...